These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 6719385

  • 1. The interaction of immobilized thrombin with human antithrombin III.
    Marciniak E, Gora-Maslak G.
    Thromb Haemost; 1984 Feb 28; 51(1):27-31. PubMed ID: 6719385
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
    Tripodi A, Krachmalnicoff A, Mannucci PM.
    Thromb Haemost; 1986 Dec 15; 56(3):349-52. PubMed ID: 3563966
    [Abstract] [Full Text] [Related]

  • 7. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M, Petersen LC, Thorsen S.
    J Lab Clin Med; 1984 Aug 15; 104(2):245-56. PubMed ID: 6747440
    [Abstract] [Full Text] [Related]

  • 8. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S, Bara L, Fessi H, Samama MM.
    Blood Coagul Fibrinolysis; 2000 Jan 15; 11(1):51-9. PubMed ID: 10691099
    [Abstract] [Full Text] [Related]

  • 9. Adverse effect of heparin in thrombin-antithrombin III interaction.
    Marciniak E.
    Thromb Diath Haemorrh; 1975 Dec 15; 34(3):748-62. PubMed ID: 1209544
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effects of human thrombomodulin on the inactivation of thrombin by its serum inhibitors.
    Thompson EA, Salem HH.
    Thromb Haemost; 1987 Oct 28; 58(3):806-10. PubMed ID: 2829375
    [Abstract] [Full Text] [Related]

  • 13. Fate of thrombin and thrombin-antithrombin-III complex adsorbed to a heparinized biomaterial: analysis of the enzyme-inhibitor complexes displaced by plasma.
    Hatton MW, Rollason G, Sefton MV.
    Thromb Haemost; 1983 Dec 30; 50(4):873-7. PubMed ID: 6198746
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA, Pastorova VE, Liapina LA.
    Biokhimiia; 1981 Nov 30; 46(11):2024-9. PubMed ID: 7317530
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA, Pastorova VE, Lyapina LA.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983 Nov 30; 110(5):731-42. PubMed ID: 6198257
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.